Sichuan Cancer Hospital And Research Institute

This study tested a combination treatment for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) whose cancer continued to grow after standard chemotherapy. The treatment combined a targeted drug (apatinib), an immunotherapy (PD-1 antibody), and a p…

This study tested whether adding the drug aprepitant to standard anti-nausea medicines could better prevent nausea and vomiting caused by chemotherapy in 143 women with gynecologic cancers like ovarian or cervical cancer. Participants received either the three-drug combo or a pla…